Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer, utilizing its OncoMimics™ peptides to generate immune responses against various tumor types
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer, utilizing its OncoMimics™ peptides to generate immune responses against various tumor types.